vs
Chewy, Inc.（CHWY）与Solventum（SOLV）财务数据对比。点击上方公司名可切换其他公司
Chewy, Inc.的季度营收约是Solventum的1.6倍（$3.1B vs $2.0B），Solventum净利率更高（3.2% vs 1.9%，领先1.3%），Chewy, Inc.同比增速更快（8.3% vs -3.7%），Chewy, Inc.自由现金流更多（$175.8M vs $32.0M），过去两年Chewy, Inc.的营收复合增速更高（4.6% vs -0.4%）
Chewy Inc.是总部位于美国佛罗里达州普兰泰申的宠物用品线上零售商，主营宠物食品及各类宠物相关产品，2019年于纽约证券交易所挂牌上市，股票代码CHWY，是北美知名的宠物电商平台，为宠物主提供丰富可靠的一站式宠物消费选购服务。
Solventum是一家总部位于美国的医疗健康企业，于2024年4月1日正式从全球知名多元化工业集团3M分拆后独立运营，继承了原3M旗下医疗板块的技术积累与业务资源，面向全球市场提供专业医疗相关产品及服务。
CHWY vs SOLV — 直观对比
营收规模更大
CHWY
是对方的1.6倍
$2.0B
营收增速更快
CHWY
高出12.0%
-3.7%
净利率更高
SOLV
高出1.3%
1.9%
自由现金流更多
CHWY
多$143.8M
$32.0M
两年增速更快
CHWY
近两年复合增速
-0.4%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.1B | $2.0B |
| 净利润 | $59.2M | $63.0M |
| 毛利率 | 29.8% | 51.4% |
| 营业利润率 | 2.1% | 6.3% |
| 净利率 | 1.9% | 3.2% |
| 营收同比 | 8.3% | -3.7% |
| 净利润同比 | 1405.6% | 103.2% |
| 每股收益（稀释后） | $0.14 | $0.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CHWYSOLV
| Q4 25 | $3.1B | $2.0B | ||
| Q3 25 | $3.1B | $2.1B | ||
| Q2 25 | $3.1B | $2.2B | ||
| Q1 25 | $3.2B | $2.1B | ||
| Q4 24 | $2.9B | $2.1B | ||
| Q3 24 | $2.9B | $2.1B | ||
| Q2 24 | $2.9B | $2.1B | ||
| Q1 24 | $2.8B | $2.0B |
净利润CHWYSOLV
| Q4 25 | $59.2M | $63.0M | ||
| Q3 25 | $62.0M | $1.3B | ||
| Q2 25 | $62.4M | $90.0M | ||
| Q1 25 | $22.8M | $137.0M | ||
| Q4 24 | $3.9M | $31.0M | ||
| Q3 24 | $299.1M | $122.0M | ||
| Q2 24 | $66.9M | $89.0M | ||
| Q1 24 | $34.3M | $237.0M |
毛利率CHWYSOLV
| Q4 25 | 29.8% | 51.4% | ||
| Q3 25 | 30.4% | 54.2% | ||
| Q2 25 | 29.6% | 54.4% | ||
| Q1 25 | 28.5% | 53.8% | ||
| Q4 24 | 29.3% | 53.9% | ||
| Q3 24 | 29.5% | 56.0% | ||
| Q2 24 | 29.7% | 54.6% | ||
| Q1 24 | 28.2% | 58.1% |
营业利润率CHWYSOLV
| Q4 25 | 2.1% | 6.3% | ||
| Q3 25 | 2.2% | 80.6% | ||
| Q2 25 | 2.5% | 9.9% | ||
| Q1 25 | -0.3% | 7.3% | ||
| Q4 24 | 0.9% | 6.6% | ||
| Q3 24 | 1.1% | 13.2% | ||
| Q2 24 | 2.2% | 11.7% | ||
| Q1 24 | -0.7% | 18.9% |
净利率CHWYSOLV
| Q4 25 | 1.9% | 3.2% | ||
| Q3 25 | 2.0% | 60.4% | ||
| Q2 25 | 2.0% | 4.2% | ||
| Q1 25 | 0.7% | 6.6% | ||
| Q4 24 | 0.1% | 1.5% | ||
| Q3 24 | 10.5% | 5.9% | ||
| Q2 24 | 2.3% | 4.3% | ||
| Q1 24 | 1.2% | 11.8% |
每股收益（稀释后）CHWYSOLV
| Q4 25 | $0.14 | $0.37 | ||
| Q3 25 | $0.14 | $7.22 | ||
| Q2 25 | $0.15 | $0.51 | ||
| Q1 25 | $0.07 | $0.78 | ||
| Q4 24 | $0.01 | $0.18 | ||
| Q3 24 | $0.68 | $0.70 | ||
| Q2 24 | $0.15 | $0.51 | ||
| Q1 24 | $0.08 | $1.37 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $701.5M | $878.0M |
| 总债务越低越好 | — | $5.0B |
| 股东权益账面价值 | $469.4M | $5.0B |
| 总资产 | $3.3B | $14.3B |
| 负债/权益比越低杠杆越低 | — | 1.00× |
8季度趋势，按日历期对齐
现金及短期投资CHWYSOLV
| Q4 25 | $701.5M | $878.0M | ||
| Q3 25 | $591.8M | $1.6B | ||
| Q2 25 | $616.4M | $492.0M | ||
| Q1 25 | $596.7M | $534.0M | ||
| Q4 24 | $507.5M | $762.0M | ||
| Q3 24 | $695.0M | $772.0M | ||
| Q2 24 | $1.1B | $897.0M | ||
| Q1 24 | $1.1B | $996.0M |
总债务CHWYSOLV
| Q4 25 | — | $5.0B | ||
| Q3 25 | — | $5.1B | ||
| Q2 25 | — | $7.8B | ||
| Q1 25 | — | $7.9B | ||
| Q4 24 | — | $8.0B | ||
| Q3 24 | — | $8.1B | ||
| Q2 24 | — | $8.3B | ||
| Q1 24 | — | $8.3B |
股东权益CHWYSOLV
| Q4 25 | $469.4M | $5.0B | ||
| Q3 25 | $389.9M | $5.0B | ||
| Q2 25 | $375.6M | $3.6B | ||
| Q1 25 | $261.5M | $3.3B | ||
| Q4 24 | $223.4M | $3.0B | ||
| Q3 24 | $486.7M | $3.2B | ||
| Q2 24 | $642.9M | $2.9B | ||
| Q1 24 | $510.2M | $3.9B |
总资产CHWYSOLV
| Q4 25 | $3.3B | $14.3B | ||
| Q3 25 | $3.1B | $14.0B | ||
| Q2 25 | $3.1B | $15.1B | ||
| Q1 25 | $3.0B | $14.5B | ||
| Q4 24 | $3.0B | $14.5B | ||
| Q3 24 | $3.1B | $14.7B | ||
| Q2 24 | $3.2B | $14.6B | ||
| Q1 24 | $3.2B | $14.7B |
负债/权益比CHWYSOLV
| Q4 25 | — | 1.00× | ||
| Q3 25 | — | 1.03× | ||
| Q2 25 | — | 2.14× | ||
| Q1 25 | — | 2.43× | ||
| Q4 24 | — | 2.71× | ||
| Q3 24 | — | 2.54× | ||
| Q2 24 | — | 2.90× | ||
| Q1 24 | — | 2.16× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $207.9M | $95.0M |
| 自由现金流经营现金流 - 资本支出 | $175.8M | $32.0M |
| 自由现金流率自由现金流/营收 | 5.6% | 1.6% |
| 资本支出强度资本支出/营收 | 1.0% | 3.2% |
| 现金转化率经营现金流/净利润 | 3.51× | 1.51× |
| 过去12个月自由现金流最近4个季度 | $487.0M | $-10.0M |
8季度趋势，按日历期对齐
经营现金流CHWYSOLV
| Q4 25 | $207.9M | $95.0M | ||
| Q3 25 | $133.9M | $76.0M | ||
| Q2 25 | $86.4M | $169.0M | ||
| Q1 25 | $207.5M | $29.0M | ||
| Q4 24 | $183.5M | $219.0M | ||
| Q3 24 | $123.4M | $169.0M | ||
| Q2 24 | $81.9M | $355.0M | ||
| Q1 24 | $98.9M | $442.0M |
自由现金流CHWYSOLV
| Q4 25 | $175.8M | $32.0M | ||
| Q3 25 | $105.9M | $-21.0M | ||
| Q2 25 | $48.7M | $59.0M | ||
| Q1 25 | $156.6M | $-80.0M | ||
| Q4 24 | $151.8M | $92.0M | ||
| Q3 24 | $91.5M | $76.0M | ||
| Q2 24 | $52.6M | $297.0M | ||
| Q1 24 | $66.5M | $340.0M |
自由现金流率CHWYSOLV
| Q4 25 | 5.6% | 1.6% | ||
| Q3 25 | 3.4% | -1.0% | ||
| Q2 25 | 1.6% | 2.7% | ||
| Q1 25 | 4.8% | -3.9% | ||
| Q4 24 | 5.3% | 4.4% | ||
| Q3 24 | 3.2% | 3.7% | ||
| Q2 24 | 1.8% | 14.3% | ||
| Q1 24 | 2.3% | 16.9% |
资本支出强度CHWYSOLV
| Q4 25 | 1.0% | 3.2% | ||
| Q3 25 | 0.9% | 4.6% | ||
| Q2 25 | 1.2% | 5.1% | ||
| Q1 25 | 1.6% | 5.3% | ||
| Q4 24 | 1.1% | 6.1% | ||
| Q3 24 | 1.1% | 4.5% | ||
| Q2 24 | 1.0% | 2.8% | ||
| Q1 24 | 1.1% | 5.1% |
现金转化率CHWYSOLV
| Q4 25 | 3.51× | 1.51× | ||
| Q3 25 | 2.16× | 0.06× | ||
| Q2 25 | 1.38× | 1.88× | ||
| Q1 25 | 9.10× | 0.21× | ||
| Q4 24 | 46.66× | 7.06× | ||
| Q3 24 | 0.41× | 1.39× | ||
| Q2 24 | 1.22× | 3.99× | ||
| Q1 24 | 2.89× | 1.86× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CHWY
暂无分部数据
SOLV
| Infection Prevention And Surgical Solutions | $752.0M | 38% |
| Cost Of Software And Rentals | $508.0M | 25% |
| Health Information Systems Segment | $347.0M | 17% |
| Dental Solutions Segment | $343.0M | 17% |
| Related Party | $14.0M | 1% |
